Clin Mol Hepatol.
2020 Jul;26(3):305-308. 10.3350/cmh.2020.0096.
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2504503
- DOI: http://doi.org/10.3350/cmh.2020.0096
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Treatment options after sorafenib failure in patients with hepatocellular carcinoma
- Systemic Therapy for Advanced Hepatocellular Carcinoma: Targeted Therapy and Immunotherapy
- A Case of Achieving Complete Remission with Combination of Sorafenib and Tegafur in Patients with Hepatocellular Carcinoma with Progression of Disease after Sorafenib Therapy
- Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
- Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
